June 11, 2019 – Although pharmaceutical advertisers have been able to stop legislation to eliminate or reduce the deductibility of drug advertising as a business expense in the past, the times, politics and a pressing need for revenue have changed the equation, according to Jim Davidson, chair of The Advertising Coalition. “It is very much […]
Read more
Jan. 13, 2017 – An amendment introduced by Sen. Al Franken (D-Minn.) to eliminate the tax deduction for drug marketing costs was not included in this week’s Senate voting on the repeal of the Affordable Care Act, thanks to immediate action by The Advertising Coalition (TAC), which focused on messages to all Senate offices that […]
Read moreJune 7, 2016 – The Advertising Coalition (TAC) Executive Director Jim Davidson gave industry’s next generation a comprehensive overview of the battle the prescription drug industry has fought over the years to protect its right to advertise at the recent Coalition for Healthcare Communication Rising Leaders Conference held in May in Washington, D.C. Davidson summarized […]
Read moreJan. 12, 2016 – As criticism of prescription drug direct-to-consumer (DTC) advertising continues to be levied by presidential hopefuls and others who blame DTC ads for both higher drug prices and a greater demand for drugs, industry organizations are preparing for what may be a long battle. Although it is unlikely that any action will […]
Read more